| 1 | The western diet and lifestyle and diseases of civilization (10.2147/rrcc.s16919) | Abstract References ORCID | 162.55 | 146 |
| 2 | Ensemble approach for developing a smart heart disease predi… (10.2147/rrcc.s172035) | Abstract References ORCID | 121.74 | 41 |
| 3 | Improving medication adherence of patients with chronic hear… (10.2147/rrcc.s50658) | Abstract References ORCID | 103.52 | 23 |
| 4 | Central aortic blood pressure and augmentation index: compar… (10.2147/rrcc.s30994) | Abstract References ORCID | 83.55 | 12 |
| 5 | Role of vitamins in cardiovascular health and disease (10.2147/rrcc.s44465) | Abstract References ORCID | 75.00 | 9 |
| 6 | Clinical utility of landiolol for use in coronary CT angiogr… (10.2147/rrcc.s77559) | Abstract References ORCID | 75.00 | 9 |
| 7 | Uncontrolled hypertension and associated factors among adult… (10.2147/rrcc.s132126) | Abstract References | 73.86 | 29 |
| 8 | Galectin-3: clinical utility and prognostic value in patient… (10.2147/rrcc.s28562) | Abstract References ORCID | 71.57 | 8 |
| 9 | Eisenmenger syndrome: current perspectives (10.2147/rrcc.s117838) | Abstract References ORCID | 67.73 | 7 |
| 10 | Psychocardiology: the spectrum of stress in the genesis of h… (10.2147/rrcc.s31074) | Abstract References ORCID | 63.38 | 6 |
| 11 | Takotsubo cardiomyopathy: etiology, diagnosis, and optimal m… (10.2147/rrcc.s46021) | Abstract References ORCID | 63.38 | 6 |
| 12 | Potential of PCSK9 as a new target for the management of LDL… (10.2147/rrcc.s52961) | Abstract References ORCID | 63.38 | 6 |
| 13 | Real-time three-dimensional speckle tracking echocardiograph… (10.2147/rrcc.s107374) | Abstract References ORCID | 58.36 | 5 |
| 14 | Current and emerging catheter technologies for percutaneous… (10.2147/rrcc.s47217) | Abstract References ORCID | 58.36 | 5 |
| 15 | Moving beyond LDL-C: incorporating lipoprotein particle numb… (10.2147/rrcc.s14825) | Abstract References ORCID | 52.42 | 4 |
| 16 | Advances in coronary stent technology: current expectations… (10.2147/rrcc.s34408) | Abstract References ORCID | 52.42 | 4 |
| 17 | Role of digoxin in controlling the ventricular rate during a… (10.2147/rrcc.s44919) | Abstract References ORCID | 52.42 | 4 |
| 18 | Heart failure self-care interventions to reduce clinical eve… (10.2147/rrcc.s48424) | Abstract References ORCID | 52.42 | 4 |
| 19 | <p>Computational modeling of balloon-expandable stent… (10.2147/rrcc.s173086) | Abstract References | 50.00 | 9 |
| 20 | Peripartum cardiomyopathy: challenges and solutions (10.2147/rrcc.s103577) | Abstract References ORCID | 45.15 | 3 |
| 21 | Cardiovascular disease among patients attending a specialist… (10.2147/rrcc.s14779) | Abstract References ORCID | 45.15 | 3 |
| 22 | Biomarkers in the prediction and management of acute coronar… (10.2147/rrcc.s36294) | Abstract References ORCID | 45.15 | 3 |
| 23 | Cardiac cachexia and muscle wasting: definition, physiopatho… (10.2147/rrcc.s41513) | Abstract References ORCID | 45.15 | 3 |
| 24 | &ldquo;Mitochondrial remodeling&rdquo; in coronary h… (10.2147/rrcc.s43364) | Abstract References ORCID | 45.15 | 3 |
| 25 | Dobutamine stress echocardiography: a review and update (10.2147/rrcc.s43947) | Abstract References ORCID | 45.15 | 3 |
| 26 | Multielectrode phased radiofrequency ablation compared with… (10.2147/rrcc.s56112) | Abstract References ORCID | 45.15 | 3 |
| 27 | Pulmonary vein isolation in the treatment of atrial fibrilla… (10.2147/rrcc.s56549) | Abstract References ORCID | 45.15 | 3 |
| 28 | Relationship between plasma apolipoprotein B concentrations… (10.2147/rrcc.s65976) | Abstract References ORCID | 45.15 | 3 |
| 29 | The Freedom SOLO bovine pericardial stentless valve (10.2147/rrcc.s72978) | Abstract References ORCID | 45.15 | 3 |
| 30 | Noncardiac chest pain: systematic review of the literature o… (10.2147/rrcc.s155441) | Abstract References | 38.91 | 5 |
| 31 | Frequency of coronary artery stenosis in patients with asymp… (10.2147/rrcc.s101805) | Abstract References ORCID | 35.78 | 2 |
| 32 | Self-reported prevalence of heart attacks and strokes in Jam… (10.2147/rrcc.s13649) | Abstract References ORCID | 35.78 | 2 |
| 33 | Intravascular ultrasound-guided percutaneous coronary interv… (10.2147/rrcc.s140850) | Abstract References ORCID | 35.78 | 2 |
| 34 | Prevalence and characteristics of dysfunction of right vent… (10.2147/rrcc.s141572) | Abstract References ORCID | 35.78 | 2 |
| 35 | <p>Brugada syndrome: updated perspectives</p> (10.2147/rrcc.s182162) | Abstract References ORCID | 35.78 | 2 |
| 36 | Acute idiopathic pericarditis: current immunological theorie… (10.2147/rrcc.s20463) | Abstract References ORCID | 35.78 | 2 |
| 37 | Ventricular assist devices for heart failure: a focus on pat… (10.2147/rrcc.s48886) | Abstract References ORCID | 35.78 | 2 |
| 38 | Myocardial T1 mapping: where are we now and where are we goi… (10.2147/rrcc.s50891) | Abstract References ORCID | 35.78 | 2 |
| 39 | Possible space flight-induced catecholamine cardiomyopathy:… (10.2147/rrcc.s56045) | Abstract References ORCID | 35.78 | 2 |
| 40 | Hyperkalemia in heart failure patients: current challenges a… (10.2147/rrcc.s75680) | Abstract References ORCID | 35.78 | 2 |
| 41 | Prevalence and predictors of left ventricular dysfunction am… (10.2147/rrcc.s159472) | Abstract References | 34.95 | 4 |
| 42 | <p>Mycotic pseudoaneurysm in intravenous drug users: c… (10.2147/rrcc.s161698) | Abstract References | 34.95 | 4 |
| 43 | Utilization and Optimization of Beta-Blockers on Heart Failu… (10.2147/rrcc.s408047) | Abstract ORCID | 23.86 | 2 |
| 44 | Transcription factor 21 gene polymorphism in patients with c… (10.2147/rrcc.s121617) | Abstract References ORCID | 22.58 | 1 |
| 45 | Meta-analysis of B-type natriuretic peptide in diagnosis of… (10.2147/rrcc.s15187) | Abstract References ORCID | 22.58 | 1 |
| 46 | Dabigatran and other oral antithrombotic agents for the prev… (10.2147/rrcc.s15248) | Abstract References ORCID | 22.58 | 1 |
| 47 | High-density lipoproteins: a novel therapeutic target for ca… (10.2147/rrcc.s15600) | Abstract References ORCID | 22.58 | 1 |
| 48 | Leukocytosis: a risk factor for myocardial infarction (10.2147/rrcc.s30023) | Abstract References ORCID | 22.58 | 1 |
| 49 | Azilsartan alone and in combination for the treatment of hyp… (10.2147/rrcc.s34791) | Abstract References ORCID | 22.58 | 1 |
| 50 | SERCA2a: its role in the development of heart failure and as… (10.2147/rrcc.s38614) | Abstract References ORCID | 22.58 | 1 |